| The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies PM Brunner, E Guttman-Yassky, DYM Leung Journal of Allergy and Clinical Immunology 139 (4), S65-S76, 2017 | 600 | 2017 |
| Increasing comorbidities suggest that atopic dermatitis is a systemic disorder PM Brunner, JI Silverberg, E Guttman-Yassky, AS Paller, K Kabashima, ... Journal of Investigative Dermatology 137 (1), 18-25, 2017 | 372 | 2017 |
| Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin H Esaki, PM Brunner, Y Renert-Yuval, T Czarnowicki, T Huynh, G Tran, ... Journal of Allergy and Clinical Immunology 138 (6), 1639-1651, 2016 | 369 | 2016 |
| Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: a … E Guttman-Yassky, PM Brunner, AU Neumann, S Khattri, AB Pavel, ... Journal of the American Academy of Dermatology 78 (5), 872-881. e6, 2018 | 309 | 2018 |
| The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins PM Brunner, M Suárez-Fariñas, H He, K Malik, HC Wen, J Gonzalez, ... Scientific reports 7 (1), 8707, 2017 | 227 | 2017 |
| Efficacy and safety of ustekinumab treatment in adults with moderate‐to‐severe atopic dermatitis S Khattri, PM Brunner, S Garcet, R Finney, SR Cohen, M Oliva, R Dutt, ... Experimental dermatology 26 (1), 28-35, 2017 | 227 | 2017 |
| Early-onset pediatric atopic dermatitis is characterized by TH2/TH17/TH22-centered inflammation and lipid alterations PM Brunner, A Israel, N Zhang, A Leonard, HC Wen, T Huynh, G Tran, ... Journal of Allergy and Clinical Immunology 141 (6), 2094-2106, 2018 | 218 | 2018 |
| Racial differences in atopic dermatitis PM Brunner, E Guttman-Yassky Annals of Allergy, Asthma & Immunology 122 (5), 449-455, 2019 | 210 | 2019 |
| Changing views of the role of Langerhans cells N Romani, PM Brunner, G Stingl Journal of Investigative Dermatology 132 (3), 872-881, 2012 | 193 | 2012 |
| Immunologic, microbial, and epithelial interactions in atopic dermatitis PM Brunner, DYM Leung, E Guttman-Yassky Annals of Allergy, Asthma & Immunology 120 (1), 34-41, 2018 | 170 | 2018 |
| Immune functions of the skin C Bangert, PM Brunner, G Stingl Clinics in dermatology 29 (4), 360-376, 2011 | 167 | 2011 |
| Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab PM Brunner, AB Pavel, S Khattri, A Leonard, K Malik, S Rose, SJ On, ... Journal of Allergy and Clinical Immunology 143 (1), 142-154, 2019 | 165 | 2019 |
| Single-cell transcriptomics combined with interstitial fluid proteomics defines cell type–specific immune regulation in atopic dermatitis TB Rojahn, V Vorstandlechner, T Krausgruber, WM Bauer, N Alkon, ... Journal of Allergy and Clinical Immunology 146 (5), 1056-1069, 2020 | 123 | 2020 |
| Vascular endothelial growth factor receptor-2–induced initial endothelial cell migration depends on the presence of the urokinase Receptor GW Prager, JM Breuss, S Steurer, D Olcaydu, J Mihaly, PM Brunner, ... Circulation research 94 (12), 1562-1570, 2004 | 119 | 2004 |
| Specific roles for dendritic cell subsets during initiation and progression of psoriasis E Glitzner, A Korosec, PM Brunner, B Drobits, N Amberg, HB Schonthaler, ... EMBO molecular medicine 6 (10), 1312-1327, 2014 | 118 | 2014 |
| Interleukin‐17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities JG Krueger, PM Brunner Experimental Dermatology 27 (2), 115-123, 2018 | 104 | 2018 |
| The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease PM Brunner, H He, AB Pavel, T Czarnowicki, R Lefferdink, T Erickson, ... Journal of the American Academy of Dermatology 81 (2), 510-519, 2019 | 90 | 2019 |
| Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade C Bangert, K Rindler, T Krausgruber, N Alkon, FM Thaler, H Kurz, T Ayub, ... Science immunology 6 (55), eabe2749, 2021 | 88 | 2021 |
| Targeting CD20 in melanoma patients at high risk of disease recurrence A Pinc, R Somasundaram, C Wagner, M Hörmann, G Karanikas, A Jalili, ... Molecular Therapy 20 (5), 1056-1062, 2012 | 86 | 2012 |
| In situ mapping of innate lymphoid cells in human skin: evidence for remarkable differences between normal and inflamed skin MC Brüggen, WM Bauer, B Reininger, E Clim, C Captarencu, GE Steiner, ... Journal of Investigative Dermatology 136 (12), 2396-2405, 2016 | 83 | 2016 |
